This transcript version is not in its final form and will be updated
Clinical Status: BPC-157 is a research peptide evaluated in numerous animal models and limited human observational studies for gastrointestinal healing, musculoskeletal regeneration, and angiogenic modulation
Gonzalez-Rivas PA, Chambers M, Liu J Journal of veterinary pharmacology and therapeutics 2021
Typical format is 30 mL multi-dose vials
They buy research-grade vials from overseas sellers with no medical oversight and no guarantee that the product is sterile, accurately dosed, or even correctly labeled
Research has examined its role in: 3-adrenergic receptor upregulation and adipose tissue sensitisation studies Lipolysis stimulation and plasma glycerol elevation in adipocyte models Lipogenesis inhibition and fat accumulation prevention in diet-induced obesity models Fat oxidation and energy expenditure pathway research Metabolic flexibility and substrate oxidation studies in obese murine models Cartilage regeneration and intra-articular joint biology in osteoarthritis models Safety pharmacology genotoxicity, bioavailability, and plasma kinetics profiling Comparative hGH fragment activity studies alongside AOD9401 and native hGH AOD9604 and Adipose Tissue Research In obese Zucker rats treated with oral AOD9604 at 500 g/kg body weight for 19 days, over 50% reduction in body weight gain was observed compared to controls, accompanied by significantly increased lipolytic activity in adipose tissue
